HTL Biotechnology
Ramon Vargas is the US Head of Quality and Compliance at HTL Biotechnology since April 2022. Previously, Ramon served as the Director and Site Head of Quality at SUN PHARMA from July 2020 to August 2021. As Co-Founder and President of The Square One Group from September 2018 to December 2020, Ramon played a pivotal role in the organization's development. Additional experience includes a position as Project Manager at AM Life Science from April 2019 to July 2020, Sr. Manager of Quality Assurance at Conformis from April 2016 to April 2018, and Manager of Quality Control Operations at Vericel Corporation from April 2013 to April 2016. Earlier in career history, Ramon was the Manager of Quality Control Microbiology at Genzyme from May 2009 to April 2013. Ramon holds a Bachelor of Science degree in Biology from the University of Hartford, obtained between 1998 and 2002.
This person is not in any offices
HTL Biotechnology
HTL is the world leader in the development and production of pharmaceutical grade biopolymers used to develop life-changing treatments for millions of patients. A pioneer in the bioproduction of hyaluronic acid, HTL has developed and refined for over 30 years its innovative functional biopolymer platform that has enabled it to produce "customised" pharmaceutical grade products for the leaders of the pharmaceutical and medical devices sectors in therapeutic areas such as ophthalmology, dermatology, medical aesthetics, rheumatology and urology Thanks to its dedicated R&D team, its partnerships and its incubator, HTL is now driving innovation in the biopolymer sector. Its R&D strategy aims to address unmet medical needs by creating new types of biopolymers, modifying their physico-chemical properties, and exploring new medical applications in cutting-edge areas such as bioprinting and drug delivery. very.